You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.3 KDa. Observed: 38 KDa, reducing conditions
Mouse
Val29-Phe244
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.8 KDa. Observed: 23-38 KDa, reducing conditions
Human
Leu25-Gln167(Cys93Ser)
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 43.6 KDa. Observed: 60-70 KDa, reducing conditions
Human
Pro21-Gln167
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 65.2 KDa. Observed: 90-120 KDa, reducing conditions
Human
Phe19-Lys379
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 52.4 KDa. Observed: 70-80 KDa, reducing conditions
Human
Phe19-Thr239
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17 KDa. Observed: 14-16 KDa, reducing conditions
Human
Ser18-Asp169
Tag free
500 μg, 1 mg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 17.7 KDa. Observed: 20-23 KDa, reducing conditions
Mouse
Ser51-Leu198
N-8His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 11.1 KDa. Observed: 18-28 KDa, reducing conditions
Human
Ser2-Gly92
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57.4 KDa. Observed: 70-85 KDa, reducing conditions
Human
Lys26-Glu547
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 80% as determined by reducing SDS-PAGE.
Predicted: 56.9 KDa. Observed: 60-90 KDa, reducing conditions
Human
Asp21-Gln510
C-10His
50 μg, 500 μg, 1 mg, 10 μg
